Every Sunday, I uncover a high-quality dividend growth stock that appears to be undervalued. These pieces are published at Daily Trade Alert, which is a site that focuses on dividend growth investing, stocks, and unique investment opportunities. I’ve been writing for them for years now, and they’re just great over there. Each week, I publish an excerpt of my work here, when it’s fresh off the press. This is your opportunity to check it out. The content is totally free. I hope you enjoy!
Building significant wealth and passive income.
Sounds complicated.
Well, it’s actually very simple.
However, simple does not mean easy.
But I’ve found a strategy that makes it far easier.
Image courtesy of: Stuart Miles at FreeDigitalPhotos.net.
P.S. If you’re interested in achieving financial freedom in your life, particularly via dividend growth investing, check out some amazing resources I’ve personally used on my way to becoming financially free at 33!
What is your opinion about ABBV now that they have just aquired AGN? With ABBV is down $13 per share today, the general consensus appears to be $64B for AGN was to high!
Lori,
I’m not a fan of the move at all. It’s the total opposite of what I wanted to see AbbVie do.
That said, the reduction in market cap for AbbVie yesterday would seem to offset much, or all, of any potential value destruction from the deal. Especially since it’s coming from an already low base.
Cheers!